Update: Cerapedics PMA Application for Spine Fusion Bone Graft

Cerapedics filed the final module in the Premarket Approval (PMA) application with FDA for its investigational P-15 Peptide Enhanced Bone Graft. If approved, this will be the latest bone graft product in Cerapedics’ portfolio to leverage its proprietary P-15 Osteogenic Cell Binding Peptide.

The new P-15 Bone Graft is designed for use in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us